<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00703092</url>
  </required_header>
  <id_info>
    <org_study_id>HM11246</org_study_id>
    <secondary_id>2U54HD034449</secondary_id>
    <nct_id>NCT00703092</nct_id>
  </id_info>
  <brief_title>Pilot Study:Role of Dietary Fiber in PCOS Anovulation</brief_title>
  <official_title>Pilot Study: Role of Dietary Fiber in PCOS Anovulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether 6 months of fiber supplementation will
      improve ovulation in women with polycystic ovary syndrome (PCOS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We hypothesize that 6 months of fiber supplementation will improve ovulation in women with
      PCOS by improving insulin sensitivity independent of weight loss. In this pilot study, we
      will determine the feasibility of conducting a larger double-blind, randomized trial in women
      with PCOS to test this hypothesis. We will evaluate 15 women over a 10-month period, starting
      with a 4-month intervention-free observation period to determine the effect on ovulation of
      adding up to 22g/day of fiber supplementation to their usual weight-maintenance diets (to
      achieve 28-36 g fiber/day assuming baseline dietary fiber intake, could feasibly be
      translated into clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    P.I. left University. Study terminated
  </why_stopped>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Generate Preliminary Data on the Range of Outcome Measures at Baseline and After 6 Months of Fiber Supplementation in Terms of: Ovulation Rates, Insulin Sensitivity, Concentrations of Circulating Androgens and Satiety.</measure>
    <time_frame>10 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantify Enrollment Strategies, Retention, Compliance, Participant Characteristics, and Data Collection Challenges.</measure>
    <time_frame>10 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>PCOS</condition>
  <arm_group>
    <arm_group_label>Fiber-Stat</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 tablespoons daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fiber-Stat</intervention_name>
    <description>Liquid fiber supplement, 2 tablespoons twice daily.</description>
    <arm_group_label>Fiber-Stat</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with PCOS between the ages of 18-45 years and with a body mass index of less
             than or equal to 45

          -  Less than or equal to 8 periods annually

          -  elevated serum free testosterone concentrations

          -  normal thyroid function tests and serum prolactin

          -  exclusion of late-onset adrenal hyperplasia

          -  acceptable health based on interview, medical history,physical examination, and lab
             tests

          -  ability to comply with the requirements of the study

          -  ability and willingness to provide signed, witnessed informed consent

        Exclusion Criteria:

          -  Diabetes mellitus

          -  Clinically significant pulmonary,cardiac
             ,renal,hepatic,neurologic,psychiatric,infectious,and malignant disease

          -  high blood pressure

          -  current or recent(within 2 months prior to study entry) injection of any drugs known
             or suspected to affect reproductive function including oral
             contraceptives,metformin,thiazolidinediones,glucocorticoids, GnRH-agonists, or
             anti-androgens (spironolactone,flutamide,etc)

          -  documented or suspected history of use of recent (within one year) illicit drug abuse
             or alcoholism

          -  ingestion of any investigational drugs within 4 weeks prior to study onset

          -  pregnancy or lactation(less than or equal to 6 weeks postpartum)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paulina A Essah, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VCU General Clinical Research Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2008</study_first_submitted>
  <study_first_submitted_qc>June 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2008</study_first_posted>
  <results_first_submitted>May 27, 2014</results_first_submitted>
  <results_first_submitted_qc>June 27, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 30, 2014</results_first_posted>
  <last_update_submitted>September 8, 2017</last_update_submitted>
  <last_update_submitted_qc>September 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anovulation</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Fiber-Stat</title>
          <description>2 tablespoons daily
Fiber-Stat: Liquid fiber supplement, 2 tablespoons twice daily.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fiber-Stat</title>
          <description>2 tablespoons daily
Fiber-Stat: Liquid fiber supplement, 2 tablespoons twice daily.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Generate Preliminary Data on the Range of Outcome Measures at Baseline and After 6 Months of Fiber Supplementation in Terms of: Ovulation Rates, Insulin Sensitivity, Concentrations of Circulating Androgens and Satiety.</title>
        <time_frame>10 months</time_frame>
        <population>This study was terminated early due to lack of enrollment. No assays were run so there is no data to report.</population>
        <group_list>
          <group group_id="O1">
            <title>Fiber-Stat</title>
            <description>2 tablespoons daily
Fiber-Stat: Liquid fiber supplement, 2 tablespoons twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Generate Preliminary Data on the Range of Outcome Measures at Baseline and After 6 Months of Fiber Supplementation in Terms of: Ovulation Rates, Insulin Sensitivity, Concentrations of Circulating Androgens and Satiety.</title>
          <population>This study was terminated early due to lack of enrollment. No assays were run so there is no data to report.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quantify Enrollment Strategies, Retention, Compliance, Participant Characteristics, and Data Collection Challenges.</title>
        <time_frame>10 months</time_frame>
        <population>This study was terminated early due to lack of enrollment. No assays were run so there is no data to report.</population>
        <group_list>
          <group group_id="O1">
            <title>Fiber-Stat</title>
            <description>2 tablespoons daily
Fiber-Stat: Liquid fiber supplement, 2 tablespoons twice daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Quantify Enrollment Strategies, Retention, Compliance, Participant Characteristics, and Data Collection Challenges.</title>
          <population>This study was terminated early due to lack of enrollment. No assays were run so there is no data to report.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Fiber-Stat</title>
          <description>2 tablespoons daily
Fiber-Stat: Liquid fiber supplement, 2 tablespoons twice daily.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. John Nestler</name_or_title>
      <organization>Virginia Commonwealth University</organization>
      <phone>804-828-3389</phone>
      <email>jnestler@mcvh-vcu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

